title: [Triamcinolone acetonide in the treatment of inflammation after cataract surgery].
abstract: OBJECTIVE
  To compare the use of single injection of triamcinolone acetonide and steroid drops in the treatment of inflammation after cataract surgery.
  
  
  METHODS
  This retrospective study included 80 patients operated on by phacoemulsification with intraocular lens implantation. After the operation, patients were divided into two groups. Group A received dexamethasone-neomycin drops for four weeks, whereas group B received single application of triamcinolone acetonide into the subtenon space. Postoperative evaluation included the degree of inflammation, intraocular pressure and therapeutic response.
  
  
  RESULTS
  Triamcinolone acetonide appeared to be an as valuable therapy in minimizing inflammation after cataract surgery as steroid drops on days 7, 14 and 21 postoperatively, a significantly lower intraocular pressure was recorded in the group of patients administered a single injection of triamcinolone acetonide.
  
  
  CONCLUSIONS
  Single application of triamcinolone acetonide appeared to be as efficient as steroid drops in controlling postoperative inflammation after uncomplicated cataract surgery.
authors.affiliation: Klinika za ocne bolesti, Klinicka bolnica Sestre milosrdnice, Zagreb, Hrvatska.
authors.forename: Valentina
authors.initials: V
authors.lastname: Lacmanović Loncar
authors.forename: Ivanka
authors.initials: I
authors.lastname: Petric
authors.forename: Zoran
authors.initials: Z
authors.lastname: Vatavuk
authors.forename: Tea
authors.initials: T
authors.lastname: Musulin
authors.forename: Katia
authors.initials: K
authors.lastname: Novak-Laus
authors.forename: Renata
authors.initials: R
authors.lastname: Iveković
authors.forename: Zdravko
authors.initials: Z
authors.lastname: Mandić
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007249:Inflammation; D007267:Injections; D007430:Intraoperative Care; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage; D009883:Ophthalmic Solutions; D018918:Phacoemulsification / Q000009:adverse effects*; D011183:Postoperative Complications / Q000517:prevention & control*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D003907:Dexamethasone; D014222:Triamcinolone Acetonide; D009355:Neomycin